Terms: = Lung cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Diagnosis
6 results:
1. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
2. Label-Free Nanoplasmonic Biosensing of cancer Biomarkers for Clinical diagnosis.
Portela A; Peláez EC; Calvo-Lozano O; Estévez MC; Lechuga LM
Methods Mol Biol; 2019; 2027():115-140. PubMed ID: 31309477
[TBL] [Abstract] [Full Text] [Related]
3. Potential Medication-Related Problems in Older Breast, Colon, and lung cancer Patients in the United States.
Lund JL; Sanoff HK; Peacock Hinton S; Muss HB; Pate V; Stürmer T
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):41-49. PubMed ID: 28978563
[No Abstract] [Full Text] [Related]
4. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
Alkan A; Yaşar A; Karcı E; Köksoy EB; Ürün M; Şenler FÇ; Ürün Y; Tuncay G; Ergün H; Akbulut H
Support Care Cancer; 2017 Jan; 25(1):229-236. PubMed ID: 27619388
[TBL] [Abstract] [Full Text] [Related]
5. pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
[TBL] [Abstract] [Full Text] [Related]
6. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract] [Full Text] [Related]
